Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.040 (3.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
Boundless Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 14.98 | 26.59 | 23.71 | 10.95 | 34.29 |
| Short-Term Investments | 102.59 | 125.53 | 97.05 | 55.77 | 38.74 |
| Cash & Short-Term Investments | 117.57 | 152.11 | 120.75 | 66.72 | 73.03 |
| Cash Growth | -29.66% | 25.97% | 80.99% | -8.65% | - |
| Prepaid Expenses | 2.59 | 2.28 | 3.45 | 1.32 | 1.54 |
| Total Current Assets | 120.16 | 154.39 | 124.2 | 68.04 | 74.57 |
| Property, Plant & Equipment | 47.98 | 51.36 | 4.58 | 7.73 | 3.1 |
| Long-Term Investments | - | - | - | - | 34.99 |
| Other Long-Term Assets | 0.59 | 0.66 | 1.12 | 1.07 | 1.07 |
| Total Assets | 168.72 | 206.41 | 129.89 | 76.83 | 113.72 |
| Accounts Payable | 1.14 | 1.27 | 2.22 | 1.4 | 1.08 |
| Accrued Expenses | 7.66 | 6.86 | 4.94 | 3.9 | 2.08 |
| Current Portion of Leases | 3.05 | - | 2.2 | 2.34 | 0.38 |
| Other Current Liabilities | - | - | - | 0.09 | 0.34 |
| Total Current Liabilities | 11.85 | 8.14 | 9.36 | 7.73 | 3.87 |
| Long-Term Leases | 46.71 | 47.63 | - | 2.85 | - |
| Other Long-Term Liabilities | - | - | - | 0.01 | 0.1 |
| Total Liabilities | 58.55 | 55.77 | 9.36 | 10.58 | 3.96 |
| Common Stock | 0 | 0 | - | 0 | 0 |
| Additional Paid-In Capital | 356.9 | 351.99 | 8.99 | 5.38 | 2.76 |
| Retained Earnings | -246.78 | -201.47 | -136.11 | -86.68 | -40.77 |
| Comprehensive Income & Other | 0.05 | 0.12 | 0.04 | -0.4 | -0.18 |
| Total Common Equity | 110.17 | 150.64 | -127.08 | -81.7 | -38.19 |
| Shareholders' Equity | 110.17 | 150.64 | 120.54 | 66.25 | 109.76 |
| Total Liabilities & Equity | 168.72 | 206.41 | 129.89 | 76.83 | 113.72 |
| Total Debt | 49.76 | 47.63 | 2.2 | 5.18 | 0.38 |
| Net Cash (Debt) | 67.81 | 104.48 | 118.56 | 61.53 | 72.66 |
| Net Cash Growth | -59.40% | -11.87% | 92.67% | -15.31% | - |
| Net Cash Per Share | 3.04 | 6.15 | 97.50 | 56.05 | 84.43 |
| Filing Date Shares Outstanding | 22.38 | 22.3 | 1.25 | 1.13 | 0.86 |
| Total Common Shares Outstanding | 22.38 | 22.3 | 1.25 | 1.13 | 0.86 |
| Working Capital | 108.31 | 146.26 | 114.85 | 60.31 | 70.7 |
| Book Value Per Share | 4.92 | 6.76 | -102.02 | -71.99 | -44.38 |
| Tangible Book Value | 110.17 | 150.64 | -127.08 | -81.7 | -38.19 |
| Tangible Book Value Per Share | 4.92 | 6.76 | -102.02 | -71.99 | -44.38 |
| Machinery | 7.12 | 7.05 | 5.25 | 4.69 | 3.7 |
| Leasehold Improvements | 1.03 | 0.98 | 0.05 | 0.05 | 0.2 |
Source: S&P Capital IQ. Standard template. Financial Sources.